Business
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
Hi, what are you looking for?
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
– Gideon Barazani, a former senior engineer at Iscar, sought compensation for Iscar patents. – – Sources inform ”Globes” that, after a legal battle...
– Mylan CEO Heather Bresch: Teva’s suit against the FDA was simply a desperate, last minute tactic. – – “We continue to see no...
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – – Teva Pharmaceutical Industries Ltd. TEVATEVA (NYSE: ;...
– Researchers at the Hebrew university of Jerusalem have created a molecule that could potentially lower diabetic patients’ higher risk of developing dementia or Alzheimer’s disease, and pave...
– Teva expects the Supreme Court to hear the case in April, a month before the Copaxone patents expire. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
– The Southern District of New York dismissed Teva’s lawsuit against Mylan for the infringement of patents on its MS treatment. – Teva Pharmaceutical...
– Apoptosis – /By Alan Gallindoss / Apotex has developed new molecular-level imaging technology to detect diseases within human cells, and potentially help therapeutically...
– /By Itzhak Dannon / As we have recently reported, Pfizer, the world’s largest pharmaceutical company filed, over a month ago, a civil suit against...
– – /By Jewish Business News Correspondent / Kamada Ltd. (Nasdaq and TASE: KMDA) today announced that the Company was granted two key patents related...